NASDAQ:AMBI

AMBI (AMBI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.07
$3.47
50-Day Range
N/A
52-Week Range
N/A
Volume
4,797 shs
Average Volume
6,181 shs
Market Capitalization
$173.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AMBI stock logo

About AMBI Stock (NASDAQ:AMBI)

Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

AMBI Stock News Headlines

These 74 robotics companies are hiring
See More Headlines
Receive AMBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/06/2014
Today
5/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Sanitary services
Sub-Industry
N/A
Current Symbol
NASDAQ:AMBI
Fax
N/A
Employees
5,041
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$326.33 million
Cash Flow
$5.59 per share
Book Value
$10.21 per share

Miscellaneous

Free Float
46,544,000
Market Cap
$173.50 million
Optionable
Not Optionable
Beta
0.69
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

AMBI Stock Analysis - Frequently Asked Questions

How were AMBI's earnings last quarter?

AMBI (NASDAQ:AMBI) issued its earnings results on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by $0.03. The biopharmaceutical company had revenue of $0.03 million for the quarter, compared to analysts' expectations of $3.50 million.

What other stocks do shareholders of AMBI own?
This page (NASDAQ:AMBI) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners